Primary analysis of JUMP, a phase 3b, expanded‐access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts

2020
journal article
article
63
dc.affiliationWydział Lekarski : Klinika Hematologiipl
dc.cm.date2020-12-02
dc.cm.id98848
dc.contributor.authorAl-Ali, Haifa Kathrinpl
dc.contributor.authorGriesshammer, Martinpl
dc.contributor.authorFoltz, Lyndapl
dc.contributor.authorPalumbo, Giuseppe A.pl
dc.contributor.authorMartino, Brunopl
dc.contributor.authorPalandri, Francescapl
dc.contributor.authorLiberati, Anna Marinapl
dc.contributor.authorle Coutre, Philipppl
dc.contributor.authorGarcia-Hernandez, Carmenpl
dc.contributor.authorZaritskey, Andreypl
dc.contributor.authorTavares, Renatopl
dc.contributor.authorGupta, Vikaspl
dc.contributor.authorRaanani, Piapl
dc.contributor.authorGiraldo, Pilarpl
dc.contributor.authorHanel, Mathiaspl
dc.contributor.authorDamiani, Danielapl
dc.contributor.authorSacha, Tomasz - 133344 pl
dc.contributor.authorBouard, Catherinepl
dc.contributor.authorPaley, Carolepl
dc.contributor.authorTiwari, Ranjanpl
dc.contributor.authorMannelli, Francescopl
dc.contributor.authorVannucchi, Alessandro M.pl
dc.date.accessioned2020-12-02T10:25:36Zpl
dc.date.available2020-12-02T10:25:36Zpl
dc.date.issued2020pl
dc.date.openaccess12
dc.description.accesstimepo opublikowaniu
dc.description.number5pl
dc.description.physical888-903pl
dc.description.points140pl
dc.description.versionostateczna wersja wydawcy
dc.description.volume189pl
dc.identifier.doi10.1111/bjh.16462pl
dc.identifier.eissn1365-2141pl
dc.identifier.issn0007-1048pl
dc.identifier.projectROD UJ / Opl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/257360
dc.languageengpl
dc.language.containerengpl
dc.rightsUdzielam licencji. Uznanie autorstwa - Użycie niekomercyjne 4.0 Międzynarodowa*
dc.rights.licenceCC-BY-NC
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/legalcode.pl*
dc.share.typeinne
dc.subtypeArticlepl
dc.titlePrimary analysis of JUMP, a phase 3b, expanded‐access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet countspl
dc.title.journalBritish Journal of Haematologypl
dc.typeJournalArticlepl
dspace.entity.typePublication
dc.affiliationpl
Wydział Lekarski : Klinika Hematologii
dc.cm.date
2020-12-02
dc.cm.id
98848
dc.contributor.authorpl
Al-Ali, Haifa Kathrin
dc.contributor.authorpl
Griesshammer, Martin
dc.contributor.authorpl
Foltz, Lynda
dc.contributor.authorpl
Palumbo, Giuseppe A.
dc.contributor.authorpl
Martino, Bruno
dc.contributor.authorpl
Palandri, Francesca
dc.contributor.authorpl
Liberati, Anna Marina
dc.contributor.authorpl
le Coutre, Philipp
dc.contributor.authorpl
Garcia-Hernandez, Carmen
dc.contributor.authorpl
Zaritskey, Andrey
dc.contributor.authorpl
Tavares, Renato
dc.contributor.authorpl
Gupta, Vikas
dc.contributor.authorpl
Raanani, Pia
dc.contributor.authorpl
Giraldo, Pilar
dc.contributor.authorpl
Hanel, Mathias
dc.contributor.authorpl
Damiani, Daniela
dc.contributor.authorpl
Sacha, Tomasz - 133344
dc.contributor.authorpl
Bouard, Catherine
dc.contributor.authorpl
Paley, Carole
dc.contributor.authorpl
Tiwari, Ranjan
dc.contributor.authorpl
Mannelli, Francesco
dc.contributor.authorpl
Vannucchi, Alessandro M.
dc.date.accessionedpl
2020-12-02T10:25:36Z
dc.date.availablepl
2020-12-02T10:25:36Z
dc.date.issuedpl
2020
dc.date.openaccess
12
dc.description.accesstime
po opublikowaniu
dc.description.numberpl
5
dc.description.physicalpl
888-903
dc.description.pointspl
140
dc.description.version
ostateczna wersja wydawcy
dc.description.volumepl
189
dc.identifier.doipl
10.1111/bjh.16462
dc.identifier.eissnpl
1365-2141
dc.identifier.issnpl
0007-1048
dc.identifier.projectpl
ROD UJ / O
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/257360
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights*
Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne 4.0 Międzynarodowa
dc.rights.licence
CC-BY-NC
dc.rights.uri*
http://creativecommons.org/licenses/by-nc/4.0/legalcode.pl
dc.share.type
inne
dc.subtypepl
Article
dc.titlepl
Primary analysis of JUMP, a phase 3b, expanded‐access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts
dc.title.journalpl
British Journal of Haematology
dc.typepl
JournalArticle
dspace.entity.type
Publication

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
20
Views per month
Views per city
Krakow
4
Ashburn
3
Wroclaw
2
Dublin
1
Katowice
1
Downloads
sacha_et-al_primary_analysis_of_jump_2020.pdf
1